Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00592-022-01889-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Data-Driven Epigenetic Characterization of Morning Fatigue Severity in Oncology Patients Receiving Chemotherapy: Associations With Epigenetic Age Acceleration, Blood Cell Types, and Expression-Associated Methylation.
Cancer Med
August 2025
Department of Physiological Nursing, University of California San Francisco, San Francisco, California, USA.
Background: Moderate-to-severe fatigue commonly occurs in patients with cancer. Given the numerous roles that epigenetic processes may play in the development and severity of fatigue, the purposes of this study were to (1) use a data-driven discovery approach to evaluate for mechanisms underlying morning fatigue in a group of oncology patients receiving chemotherapy and (2) identify common biological mechanisms associated with morning fatigue severity across these independent epigenetic evaluations.
Methods: Patients completed questionnaires during the week prior to their chemotherapy treatment.
β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humans.
Hepatology
February 2025
Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Background And Aims: Hepatoblastoma (HB) is the predominant primary malignant liver tumor in childhood. Concomitant Yes-associated protein (YAP) and β-Catenin activation occurs in most HB. However, the signaling pathways distinctively regulated by YAP and β-Catenin protooncogenes in HB remain unexplored.
View Article and Find Full Text PDFA ONECUT1 regulatory, non-coding region in pancreatic development and diabetes.
Cell Rep
November 2024
Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany. Electronic address:
In a patient with permanent neonatal syndromic diabetes clinically similar to cases with ONECUT1 biallelic mutations, we identified a disease-causing deletion located upstream of ONECUT1. Through genetic, genomic, and functional studies, we identified a crucial regulatory region acting as an enhancer of ONECUT1 specifically during pancreatic development. This enhancer region contains a low-frequency variant showing a strong association with type 2 diabetes and other glycemic traits, thus extending the contribution of this region to common forms of diabetes.
View Article and Find Full Text PDFContribution of ONECUT1 variants to different forms of non-autoimmune diabetes mellitus in Italian patients.
Acta Diabetol
August 2022
Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.
Mutations and variants of ONECUT1 in diabetes.
Nat Med
November 2021
Department of Internal Medicine I, Ulm University, Ulm, Germany.
Genes involved in distinct diabetes types suggest shared disease mechanisms. Here we show that One Cut Homeobox 1 (ONECUT1) mutations cause monogenic recessive syndromic diabetes in two unrelated patients, characterized by intrauterine growth retardation, pancreas hypoplasia and gallbladder agenesis/hypoplasia, and early-onset diabetes in heterozygous relatives. Heterozygous carriers of rare coding variants of ONECUT1 define a distinctive subgroup of diabetic patients with early-onset, nonautoimmune diabetes, who respond well to diabetes treatment.
View Article and Find Full Text PDF